Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2015, Article ID 507315, 6 pages
http://dx.doi.org/10.1155/2015/507315
Research Article

The Ability of Secretory Leukocyte Protease Inhibitor to Inhibit Apoptosis in Monocytes Is Independent of Its Antiprotease Activity

1Respiratory Research Division, Department of Medicine, Education and Research Centre, Royal College of Surgeons in Ireland, Dublin 9, Ireland
2Centre for Infection and Immunity, School of Medicine, Dentistry and Biomedical Sciences, Health Sciences Building, Queen’s University Belfast, 97 Lisburn Road, Belfast BT9 7AE, UK

Received 17 March 2015; Revised 20 June 2015; Accepted 23 June 2015

Academic Editor: Selvan Senthamil

Copyright © 2015 Niamh McGarry et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Weldon, N. McGarry, C. C. Taggart, and N. G. McElvaney, “The role of secretory leucoprotease inhibitor in the resolution of inflammatory responses,” Biochemical Society Transactions, vol. 35, no. 2, pp. 273–276, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. M. G. Grütter, G. Fendrich, R. Huber, and W. Bode, “The 2.5 A X-ray crystal structure of the acid-stable proteinase inhibitor from human mucous secretions analysed in its complex with bovine alpha-chymotrypsin,” The EMBO Journal, vol. 7, no. 2, pp. 345–351, 1988. View at Google Scholar · View at Scopus
  3. S. Ranganathan, K. J. Simpson, D. C. Shaw, and K. R. Nicholas, “The whey acidic protein family: a new signature motif and three-dimensional structure by comparative modeling,” Journal of Molecular Graphics and Modelling, vol. 17, no. 2, pp. 106–113, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Clauss, H. Lilja, and Å. Lundwall, “A locus on human chromosome 20 contains several genes expressing protease inhibitor domains with homology to whey acidic protein,” Biochemical Journal, vol. 368, no. 1, pp. 233–242, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. B. Appelhans, B. Ender, G. Sachse, T. Nikiforov, H. Appelhans, and W. Ebert, “Secretion of antileucoprotease from a human lung tumor cell line,” FEBS Letters, vol. 224, no. 1, pp. 14–18, 1987. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Franken, C. J. L. M. Meijer, and J. H. Dijkman, “Tissue distribution of antileukoprotease and lysozyme in humans,” Journal of Histochemistry and Cytochemistry, vol. 37, no. 4, pp. 493–498, 1989. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Heinzel, H. Appelhans, G. Gassen et al., “Molecular cloning and expression of cDNA for human antileukoprotease from cervix uterus,” European Journal of Biochemistry, vol. 160, no. 1, pp. 61–67, 1986. View at Publisher · View at Google Scholar · View at Scopus
  8. C. H. Lee, Y. Igarashi, R. J. Hohman, H. Kaulbach, M. V. White, and M. A. Kaliner, “Distribution of secretory leukoprotease inhibitor in the human nasal airway,” American Review of Respiratory Disease, vol. 147, no. 3, pp. 710–716, 1993. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Vogelmeier, R. C. Hubbard, G. A. Fells et al., “Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor,” Journal of Clinical Investigation, vol. 87, no. 2, pp. 482–488, 1991. View at Publisher · View at Google Scholar · View at Scopus
  10. C. C. Taggart, G. J. Lowe, C. M. Greene et al., “Cathepsin B, L, and S cleave and inactivate secretory leucoprotease inhibitor,” The Journal of Biological Chemistry, vol. 276, no. 36, pp. 33345–33352, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. R. C. Thompson and K. Ohlsson, “Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase,” Proceedings of the National Academy of Sciences of the United States of America, vol. 83, no. 18, pp. 6692–6696, 1986. View at Publisher · View at Google Scholar · View at Scopus
  12. O. Wiedow, J. Harder, J. Bartels, V. Streit, and E. Christophers, “Antileukoprotease in human skin: an antibiotic peptide constitutively produced by keratinocytes,” Biochemical and Biophysical Research Communications, vol. 248, no. 3, pp. 904–909, 1998. View at Publisher · View at Google Scholar · View at Scopus
  13. P. S. Hiemstra, R. J. Maassen, J. Stolk, R. Heinzel-Wieland, G. J. Steffens, and J. H. Dijkman, “Antibacterial activity of antileukoprotease,” Infection and Immunity, vol. 64, no. 11, pp. 4520–4524, 1996. View at Google Scholar · View at Scopus
  14. T. B. McNeely, M. Dealy, D. J. Dripps, J. M. Orenstein, S. P. Eisenberg, and S. M. Wahl, “Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro,” The Journal of Clinical Investigation, vol. 96, no. 1, pp. 456–464, 1995. View at Publisher · View at Google Scholar · View at Scopus
  15. T. B. McNeely, D. C. Shugars, M. Rosendahl, C. Tucker, S. P. Eisenberg, and S. M. Wahl, “Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription,” Blood, vol. 90, no. 3, pp. 1141–1149, 1997. View at Google Scholar · View at Scopus
  16. F.-Y. Jin, C. Nathan, D. Radzioch, and A. Ding, “Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide,” Cell, vol. 88, no. 3, pp. 417–426, 1997. View at Publisher · View at Google Scholar · View at Scopus
  17. C. C. Taggart, S.-A. Cryan, S. Weldon et al., “Secretory leucoprotease inhibitor binds to NF-κB binding sites in monocytes and inhibits p65 binding,” The Journal of Experimental Medicine, vol. 202, no. 12, pp. 1659–1668, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Ding, N. Thieblemont, J. Zhu, F. Jin, J. Zhang, and S. Wright, “Secretory leukocyte protease inhibitor interferes with uptake of lipopolysaccharide by macrophages,” Infection and Immunity, vol. 67, no. 9, pp. 4485–4489, 1999. View at Google Scholar · View at Scopus
  19. C. C. Taggart, C. M. Greene, N. G. McElvaney, and S. O'Neill, “Secretory leucoprotease inhibitor prevents lipopolysaccharide-induced IκBα degradation without affecting phosphorylation or ubiquitination,” The Journal of Biological Chemistry, vol. 277, no. 37, pp. 33648–33653, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. C. M. Greene, N. G. McElvaney, S. J. O'Neill, and C. C. Taggart, “Secretory leucoprotease inhibitor impairs Toll-like receptor 2- and 4-mediated responses in monocytic cells,” Infection and Immunity, vol. 72, no. 6, pp. 3684–3687, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. A. B. Lentsch, J. A. Jordan, B. J. Czermak et al., “Inhibition of NF-kappaB activation and augmentation of IkappaBbeta by secretory leukocyte protease inhibitor during lung inflammation,” American Journal of Pathology, vol. 154, no. 1, pp. 239–247, 1999. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Subramaniyam, C. Hollander, U. Westin, J. Erjefält, T. Stevens, and S. Janciauskiene, “Secretory leukocyte protease inhibitor inhibits neutrophil apoptosis,” Respirology, vol. 16, no. 2, pp. 300–307, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. S. P. Eisenberg, K. K. Hale, P. Heimdal, and R. C. Thompson, “Location of the protease-inhibitory region of secretory leukocyte protease inhibitor,” The Journal of Biological Chemistry, vol. 265, no. 14, pp. 7976–7981, 1990. View at Google Scholar · View at Scopus
  24. N. Karasavvas and Z. Zakeri, “Relationships of apoptotic signaling mediated by ceramide and TNF-α in U937 cells,” Cell Death and Differentiation, vol. 6, no. 2, pp. 115–123, 1999. View at Publisher · View at Google Scholar · View at Scopus
  25. J. S. Song, C. M. Kang, C. K. Rhee et al., “Effects of elastase inhibitor on the epithelial cell apoptosis in bleomycin-induced pulmonary fibrosis,” Experimental Lung Research, vol. 35, no. 10, pp. 817–829, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Sabri, S. G. Alcott, H. Elouardighi et al., “Neutrophil cathepsin G promotes detachment-induced cardiomyocyte apoptosis via a protease-activated receptor-independent mechanism,” The Journal of Biological Chemistry, vol. 278, no. 26, pp. 23944–23954, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Yang, J. Zhu, D. Sun, and A. Ding, “Suppression of macrophage responses to bacterial lipopolysaccharide (LPS) by secretory leukocyte protease inhibitor (SLPI) is independent of its anti-protease function,” Biochimica et Biophysica Acta: Molecular Cell Research, vol. 1745, no. 3, pp. 310–317, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. M. S. Mulligan, A. B. Lentsch, M. Huber-Lang et al., “Anti-inflammatory effects of mutant forms of secretory leukocyte protease inhibitor,” The American Journal of Pathology, vol. 156, no. 3, pp. 1033–1039, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Wu, C. Parungo, G. Wu et al., “PR39 inhibits apoptosis in hypoxic endothelial cells: role of inhibitor apoptosis protein-2,” Circulation, vol. 109, no. 13, pp. 1660–1667, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Zhu, C. Nathan, W. Jin et al., “Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair,” Cell, vol. 111, no. 6, pp. 867–878, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Weldon, P. McNally, N. G. McElvaney et al., “Decreased levels of secretory leucoprotease inhibitor in the Pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradation,” The Journal of Immunology, vol. 183, no. 12, pp. 8148–8156, 2009. View at Publisher · View at Google Scholar · View at Scopus